Resident Poster

(9-001) Evaluation of a Medication Synchronization Program as a Tool for Identifying Patients at Increased Risk for Type 2 Diabetes

(9-002) Assessment of Healthcare Worker Current Practices and Readiness to Address Social Determinants of Health

(9-003) Analysis of a Remote, Pharmacist-Led Hypertension Clinic in a Rural Veteran Population

(9-004) Impact of Hyperglycemia Education on Blood Glucose Control

(9-005) Comparison of Alteplase versus Tenecteplase for Treatment of Acute Ischemic Stroke at a Large Community Hospital

(9-006) Impact of a 2000mg Loading Dose Maximum on Vancomycin in Adult Patients

(9-007) Impact of pharmacist facilitated Chronic Care Management calls compared to nurse facilitated Chronic Care Management calls on clinical markers in community dwelling adults

(9-008) Evaluation of broad-spectrum antibiotics initiated after cardiac arrest at a large community hospital

(9-009) Evaluation of Appropriate Use of Newly Implemented Sliding Scale Insulin Protocol at a Large Community Hospital

(9-010) Evaluation of Midodrine Use in Transitions of Care at a Large Community Hospital

(9-011) Evaluation of the Use of Ceftolozane/Tazobactam at a Large Community Hospital

(9-012) Evaluation of Pharmacists' Review on Discharge Medication Reconciliation in Transitions of Care

(9-013) Characterizing 24-hour pharmacist response to rapid multiplex polymerase chain reaction (rmPCR) blood culture results.

(9-014) Evaluation of prophylactic antimicrobial therapy in open skull fractures at a large community hospital

(9-015) Evaluation of Proton Pump Inhibitor Utilization at a Large Community Hospital

(9-016) Evaluation of the Impact of Increased Blood Glucose Monitoring in a Hyperkalemia Protocol at a Large Community Hospital

(9-017) Frail Patients - Evaluation of Implemented Anesthesia Order Set

(9-018) Implementation of Pharmacist-Driven Transfer Medication Reconciliation in Intensive Care Units at Huntsville Hospital Main

(9-019) Retrospective Review of Potential Propofol Related Infusion Syndrome (PRIS) at a Large Community Hospital

(9-020) Evaluation of Rapid-Acting PCR Respiratory Pathogen Testing in a Large Community Hospital

(9-021) Characterization of Levothyroxine Use in Patients Receiving Continuous Enteral Nutrition at a Large Community Hospital

(9-022) Evaluation of Granulocyte-Colony Stimulating Factor (G-CSF) Utilization at a Large Community Hospital

(9-023) Comparison of Treatment and Outcomes of Acute Hypertension in Hospitalized Patients in a Community Hospital

(9-024) Comparison of Sodium Polystyrene Sulfonate and Sodium Zirconium Cyclosilicate for the Treatment of Hyperkalemia in a Community Hospital

(9-025) Assessment of a Heparin Infusion Protocol in Obese Patients in a Community Hospital

(9-026) Assessing Appropriateness of Levetiracetam Dosing for Status Epilepticus in the Emergency Department of a Community Hospital

(9-027) Enhancing Pharmacist-led Medication Reconciliation in a Community Hospital: A Quality Improvement Initiative

(9-028) An Evaluation of Prophylactic Enoxaparin in Patients with Obesity

(9-029) Auto-verification Resulting in Medication Errors in the Emergency Department

(9-030) Economic and Clinical Impact of Staphylococcus aureus-targeted versus Expansive Molecular Rapid Diagnostic Panel Use in Gram-positive Blood Cultures

(9-031) Evaluation of Outpatient Parenteral Antimicrobial Therapy (OPAT) in a Community Healthcare System

(9-032) Effect of Bupivacaine Liposome Injectable Suspension Administration in Abdominal Surgery

(9-033) Evaluating Therapeutic and Economic Outcomes of Targeted Biologic Dose De-Escalation Interventions in a Managed Care Setting

(9-034) Prothrombin Complex Concentrate Medication Use Evaluation

(9-035) Evaluation of the Impact of Medical Billing on Documentation and Patient Outcomes in an Independent Community Pharmacy Chain

(9-036) Major Risk Factors Associated with the Development of Candidemia in Intensive Care Units at University Hospital in Mobile, AL

(9-037) Identifying the Incidence of Culture-Proven Infection and Risk Factors After Use of Probiotics in Pre-term Neonates in the NICU at an Academic Pediatric Hospital

(9-038) Comparing Iron Deficiency Anemia Management Strategies Utilizing Oral Iron Supplementation between Healthcare Providers

(9-039) Assessment of Ketamine Infusion Dose Range for Analgesia, Sedation, or Analgosedation and Risk of Delirium in Critically Ill Patients

(9-040) Prophylactic Ampicillin/sulbactam to Prevent Ventilator-Associated Pneumonia in Critically Ill Adult Patients

(9-041) A retrospective review of iron dextran hypersensitivity reactions with a one-hour infusion rate compared to a four-hour infusion rate in adults and pediatrics

(9-042) Impact of actual body weight on carboplatin induced myelosuppression in obese gynecologic cancer patients

(9-043) Rapid vs Standard Microinduction of Buprenorphine for Patients with Opioid Use Disorder

(9-044) Repeat Blood Cultures in Gram-Negative Bacteremia for Pediatrics

(9-045) A Retrospective Chart Review of Tenecteplase Utilization throughout Banner Health Following Implementation of Acute Ischemic Stroke Protocol

(9-046) Standard Versus Weight Based Dosing of Intravenous DilTIAZem in Atrial Fibrillation with Rapid Ventricular Rate

(9-047) Effect of delayed second-dose antibiotics on length of ICU stay in sepsis and septic shock cases

(9-048) Characterization of Methadone Use in At Risk Obstetric Patients

(9-049) Evaluation of Valproic Acid (VPA) for Weaning of Continuous Infusion Sedatives in Adult Patients

(9-050) Clonidine Use for Dexmedetomidine Withdrawal in Pediatric Intensive Care Unit (PICU) Patients

(9-051) Evaluation of Efficacy of Fixed-Dose 4-Factor Prothrombin Complex Concentrate (4F-PCC) vs Weight-Based Dose 4F-PCC in Patients With Major Bleeds on Factor-Xa Inhibitors

(9-052) Utilization of Continuous Intravenous Insulin for Hypertriglyceridemia-Induced Pancreatitis

(9-053) Delineating Common Prescribing Practices and Trends in Dose Escalations of Opiates in an Outpatient Oncology Center

(9-054) Carbapenems versus Carbapenem-Sparing β-Lactam Antibiotics for the Treatment of Piperacillin-Tazobactam Non-Susceptible, Ceftriaxone Susceptible Escherichia coli and Klebsiella pneumoniae Infections

(9-055) Anticoagulation Prescribing Trends in Patients with Factor V Leiden: A Retrospective Analysis

(9-056) Calcium response to intravenous bisphosphonates alone versus with calcitonin in adult patients with moderate to severe hypercalcemia: a multicenter academic retrospective chart review

(9-057) Medication Use Evaluation of Linezolid at a Rural Hospital

(9-058) Medication-Use Evaluation of Long-Acting Injectable Antipsychotics in a Rural Hospital

(9-059) Evaluating the Safety of Phenobarbital for Alcohol Withdrawal Syndrome in Patients with Mild to Moderate Traumatic Brain Injury

(9-060) Vascular Access for Parenteral Nutrition - Focus on Midline Administration

(9-061) Impact of Sleep Bundle Implementation in Postoperative Cardiothoracic Surgery Patients

(9-062) Evaluating the Safety and Efficacy of Phenobarbital Use in Patients Experiencing Alcohol Withdrawal Syndrome

(9-063) Impact of Proton Pump Inhibitor Formulary Restrictions on Acid Suppression Therapy Utilization and Outcomes

(9-064) Comparison of Phenobarbital Dosing Strategies in Patients with Alcohol Withdrawal Syndrome

(9-065) Retrospective Analysis of Outcomes After Bioprosthetic Valve Replacement With or Without Anticoagulation

(9-066) Comparison of Lacosamide and Levetiracetam for Seizure Prophylaxis in Traumatic Brain Injury: A Retrospective Cohort Study

(9-067) Evaluating Outcomes Associated with Venous Thromboembolism (VTE) Prophylaxis Initiation Post Thrombolytic Therapy in Ischemic Stroke Patients

(9-068) Retrospective Review of Guideline Directed Medical Therapy (GDMT) Medications and Occurrence of Heart Failure Readmission

(9-069) Evaluation of Rabies Vaccine and Immunoglobulin Use Within a Rural Community Hospital

(9-070) Fosfomycin in Focus: Evaluating Use Within a Rural Community Hospital

(9-071) Assessing Patient Outcomes and Clinical Engagement Following the Implementation of the FACT-G7 Survey within an Oncology Clinical Management Program

(9-072) Utilization of Predictive Analytics to Target Oncology Patients at Risk of Low Adherence

(9-073) Evaluating the Impact of Clinical Pharmacist Integration on Patient Care Outcomes in a Private Rheumatology Clinic

(9-074) Real-World Insights on Biosimilar Conversion and Persistency Following Adalimumab Originator Product Formulary Exclusion in Treatment-Experienced Patients

(9-075) Assessing the Impact of 2-week, 6-week, and 3-month Clinical Pharmacist Follow-up on Medication Adherence and Clinical Engagement in the Multiple Sclerosis Population

(9-076) A New Era of Goal Setting: The WOOP Method in Pharmacy Schools

(9-077) Assessment of Patients’ Perception and Impression of Long-Acting Injectable Buprenorphine Administration in the Community Pharmacy Setting

(9-078) Evaluating Patient Satisfaction and Perceived Economic Impact of Long-Acting Injectable Administration by Pharmacists in a Community Pharmacy Setting

(9-079) Evaluating the Safety of the 40 mEq Limit for Potassium Chloride Extended Release Tablets

(9-080) Optimizing Heparin Induced Thrombocytopenia Risk Assessment: The Role of the 4T Score in Lung Transplant Care

(9-081) Incidence and Outcomes of Pleural Effusion Culture Positivity Following Lung Transplantation

(9-082) A Pharmacists Role in Enhancing Statin Therapy for Cardiovascular Disease Prevention and Treatment in Patients with Type 2 Diabetes in a Federally Qualified Health Center

(9-083) Impact of Pharmacist Involvement on Aspirin in Secondary Prevention at a Federally Qualified Health Center

(9-084) Retrospective Chart Review Comparing Pharmacist versus Physician Dosing of Warfarin in Hospitalized Patients

(9-085) Evaluating Early Conversion to Oral Antibiotics to Reduce Length of Stay in Patients with Gram-Negative Bacteremia: A Quality Improvement Project

(9-086) Optimizing Anti-Fungal Therapy: A Study on the Implementation of Indication-Specific Prescribing Practices

(9-087) Pharmacist Driven Antibiotic Time-out for Optimizing Antibiotic Use in Decentralized Units

(9-088) A Retrospective Cohort Study Evaluating the Use of Metformin for Glucose Control in Adult Burn Patients

(9-089) Prescribing Practice of Enterobacterales Bacteremia Oral-Stepdown Therapy and Effect on Clinical Outcomes at Valleywise Health

(9-090) Analysis of non-allergic anaphylactoid reactions amongst those who receive two bag n-acetylcysteine versus three bag n-acetylcysteine

(9-091) Evaluating Guideline Directed Medical Therapy in Patients Admitted with Heart Failure

(9-092) Evaluation of Corticosteroid Dosing in Critically Ill Patients with Acute Exacerbations of Chronic Obstructive Pulmonary Disease Requiring Mechanical Ventilation

(9-093) Change in Chronic Obstructive Pulmonary Disease Assessment Test (CAT) Score after Pharmacist Intervention within Rural Federally Qualified Health Center (FQHC) Pulmonary Clinics

(9-094) Impact of Pharmacist-Led Hepatitis C Linkage to Care and Treatment Service on Cure Rates in a Federally Qualified Health Center

(9-095) Comparative Analysis of Antiretroviral Regimens and Demographic Factors in HIV Viral Load Suppression

(9-096) Characterizing Telehealth Versus In-Person Clinical Pharmacy Consult Visits in a Rural Federally Qualified Health Center

(9-097) Impact of a Pharmacist Diabetes Management Protocol Within a Telehealth Clinic at a Rural Health Center

(9-098) Impact of Midodrine Starting Dose On Time to Vasopressor Discontinuation in Shock Patients

(9-099) Comparative Analysis of Propofol versus Midazolam on Early Vasopressor Requirements in Patients with Septic Shock

(9-100) Evaluation of Guideline Based Prescribing in Urinary Tract Infections

(9-101) Evaluation of Guideline-Based Prescribing for Patients Treated for Community-Acquired Pneumonia

(9-102) Impact of pharmacist-led bedside preparation of 4-factor PCC (Balfaxar) in the emergency department

(9-103) Incidence of ventilator-associated pneumonia following elimination of chlorhexidine from standard of care for intubated patients

(9-104) Title: Assessing the impact of social determinants of health screenings for a community health worker program among specialty pharmacy services within a mass market chain.

(9-105) Impact of a Pharmacist-Led Lipid Management Service at a Hospital-Affiliated Heart and Vascular Clinic

(9-106) Appropriate Use of Antipseudomonal and Anti-MRSA Agents as Empiric Therapy for Community-Acquired Pneumonia

(9-107) Assessing the Accuracy of Initial Heparin-Induced Thrombocytopenia Diagnoses in a Community Hospital

(9-108) Rate of Acute Kidney Injury Using AUC Dosing Compared to Traditional Trough Dosing of Vancomycin

(9-109) The Association Between Proton Pump Inhibitors Use and Clostridium Difficile Infection in a Rural Community Hospital

(9-110) Evaluation of Treatment of COPD Patients Managed at University of Arkansas for Medical Sciences Capital Mall and Family Medical Center Outpatient Care Clinics

(9-111) Mind the Statin Gap – Evaluating Barriers in Pharmacy-Recommended Statin Therapy

(9-112) Impact of 4-Factor Prothrombin Complex Concentrate (4F-PCC) Protocol in Patients Not on Anticoagulants

(9-113) Impact of a Bedside Medication Delivery Service in Patients Admitted with Heart Failure

(9-114) Evaluation of phenobarbital dosing in pediatric patients undergoing extracorporeal membrane oxygenation (ECMO) with or without concomitant continuous renal replacement therapy (CRRT)

(9-115) Successful Rechallenge with Felbamate Utilizing a Rapid Desensitization and Slow Titration Scheme: A Case Report

(9-116) Case Report: The Potential Role of NK-1 Receptor Antagonists in the Management of Cannabinoid Hyperemesis Syndrome (CHS)

(9-117) Identify Risk Factors of Supra-Therapeutic Gentamicin Peak Levels in Neonatal Patients with Post-Menstrual Age Less Than or Equal to 29.0 Weeks

(9-118) Descriptive Analysis of Midazolam Based Sedation among Patients Requiring Paralysis for the Management of Acute Respiratory Distress Syndrome- An Interim Analysis

(9-119) Evaluation of hemorrhagic transformation rates associated with alteplase compared to tenecteplase in acute ischemic stroke

(9-120) Provision of Care Through Medication Therapy Management in Primary Care

(9-121) GLP-1 Agonist Prescribing Trends in Medicare Patients with Type 2 Diabetes and Cardiovascular Disease

(9-122) Extended-Infusion versus Intravenous Push Administration of Meropenem in Patients with Multi-Drug-Resistant Infection

(9-123) Assessing Inappropriate Intravenous Vancomycin Use in the Emergency Department: Exploring Unnecessary Initiation and Potential Mitigation Strategies

(9-124) Developing a Pharmacist Driven Protocol to Manage Outpatient Prescriptions Issues in the Emergency Department

(9-125) Implementation of a Skin and Soft Tissue Infection Protocol Using Methicillin-Resistant Staphylococcus aureus Polymerase Chain Reaction Wound Swabs to Guide Antibiotic De-escalation

(9-126) Evaluating Compliance With Best Practice Nursing Interventions Aimed at Reducing Mortality in the Stroke Patient Population

(9-127) Implementation of an Insulin Use Guideline for Management of Steroid-Induced Hyperglycemia in Non-Critical Care Inpatients

(9-128) Evaluating the Impact of Rapid Molecular Diagnostics on Antibiotic Stewardship and Patient Outcomes for Skin and Soft Tissue Infections

(9-129) Impact of Fixed-Dose Prothrombin Complex Concentrate (Human) versus Weight-Based Dosing in the Emergent Anticoagulation Reversal of Warfarin

(9-130) Post-Operative Opioid Utilization in Patients Receiving Peri-Operative Bupivacaine-Meloxicam or Bupivacaine Liposome Injection Suspension for Knee Replacement Surgery

(9-131) Evaluating the Appropriateness of Empiric and Directed Antifungal Therapy in Patients with Positive Candida Cultures

(9-132) Review of Clostridioides Difficile Infection (CDI) and Treatment Success Rates in Patients Initiated on Azithromycin Versus Doxycycline for the Treatment of Community Acquired Pneumonia (CAP)

(9-133) Evaluating the Implications of Initiating Immunotherapy Anti-cancer Treatment in the Inpatient Setting on Patient Outcomes, Treatment Tolerance, and Drug Costs

(9-134) Evaluation of the Economic Impact of Transitioning from Meropenem to Ertapenem as the Preferred Carbapenem for Extended Spectrum Beta-Lactamase Infections in Hospitalized Non-Critically Ill Adults

(9-135) Optimizing Survival: The Impact of Calcium-to-Blood Volume Ratios on Survival Outcomes During Massive Transfusion Protocol

(9-136) Comparison of a Continuous Intravenous Insulin Dosing Program to Clinician Insulin Dosing in Managing Diabetic Ketoacidosis or Hyperosmotic Hyperglycemic State: A Retrospective Review

(9-137) Impact After Implementation of an AUC-based Dosing Protocol for IV Vancomycin

(9-138) Development of a Pharmacist-driven Beta Lactam Allergy De-labeling Protocol

(9-140) Implementing a Pediatric Medical Emergency Training at a Community Teaching Hospital

(9-141) Comparison of Statin Use for Atherosclerotic Cardiovascular Disease Prevention in People With HIV at a Federally Qualified Health Center Clinic

(9-142) Impact of pharmacist-driven transitions-of-care program at a pediatric hospital

(9-143) Let's Take a Breather: Strategies to Optimize Use of Inhaled Nitric Oxide

(9-144) Fludarabine Pharmacokinetics: That’s a Bunch of BSA!

(9-145) Ironing Out the Differences: A Retrospective Review Evaluating the Safety, Efficacy, and Comparative Cost of Ferric Carboxymaltose versus Iron Sucrose in Pediatric Inflammatory Bowel Disease

(9-146) Sweet Insights: Exploration of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Modulator Impact on Cystic Fibrosis Related Diabetes (CFRD)

(9-147) Diuretic use and electrolyte supplementation in preterm infants with bronchopulmonary dysplasia (BPD)

(9-148) Management of Heparin IV Infusion for Patients with Oral Factor Xa Inhibitors (OFXai) Interference

(9-149) Implementation of Regional Blocks for Hip Fractures Presenting to the Emergency Department

(9-150) Efficacy and Safety of Intravenous Insulin Infusion to Treat Severe Hypertriglyceridemia

(9-151) Evaluation of a Euglycemic Diabetic Ketoacidosis Management Protocol for its Efficacy and Impact on Patient Safety

(9-152) De-escalation of Anti-MRSA Therapy with the Use of MRSA Nares PCR Screen in Skin and Soft Tissue Infections

(9-153) Evaluating the Impact of an Automated Antibiotic Time-Out Alert on Antimicrobial Usage

(9-154) Evaluation of Pharmacist Led Initiative to Substitute IV Vancomycin to IV/PO Linezolid for Pneumonia and Skin Soft Tissue Infections

(9-155) Impact of Intraoperative Methadone on Postoperative Pain Management in a Community Hospital Setting

(9-156) Comparison of Intraoperative Phenylephrine Bolus Versus Continuous Infusion in Patients Undergoing Elective Cesarean Delivery

(9-157) Effect of Antibiotic Timing and Administration Sequence on Mortality in Patients with Sepsis and Septic Shock

(9-158) Safety and Efficacy Outcomes of Micafungin in a community hospital setting in patients who were diagnosed with sepsis vs those without sepsis.

(9-159) Enteral Vancomycin as Primary Prophylaxis Against Clostridioides difficile Infection in Critically Ill Patients ​

(9-160) A comparison of subcutaneous risperidone and intramuscular paliperidone palmitate effects on 30-day readmission rates in adult patients at a safety-net psychiatric hospital: a retrospective review

(9-161) Hypnotic Use in an Adolescent Inpatient Behavioral Health Facility

(9-162) Assessing the Effectiveness of Community Pharmacist-Initiated Smoking Cessation Intervention to Tobacco Users During Immunization Encounters

(9-164) Impact of Pharmacist-facilitated Interventions on Heart Failure Patients’ Medication Therapies and Clinical Outcomes

(9-165) Evaluation of patients with low-risk pulmonary embolism (PE) and treatment plans in the Emergency Department (ED)

(9-166) Evaluating the Effect of Provider Education on the Rate of Antibiotic Treatment for Asymptomatic Bacteriuria

(9-167) Comparison of Ferric Carboxymaltose to Iron Sucrose Complex in the Management of Gestational Iron Deficiency Anemia in Ambulatory Obstetric Patients

(9-168) Assessment of Insulin Infusion Reinitiation Rates in Patients with DKA/HHS in the ICU

(9-169) Assessing Clinical Outcomes of Hospitalized Pneumonia Patients Treated with Ceftriaxone or Piperacillin-Tazobactam vs. Cefepime or Carbapenems for Serratia Marcescens, Morganella morganii, and Providencia species

(9-170) Evaluating the Appropriateness of Ordering Urinalysis in the Emergency Department

(9-171) Impact of Pharmacist-Driven Provider Education on Antibiotic Prescribing for Asymptomatic Bacteriuria in the Emergency Department at Post-Discharge Culture Follow-up

(9-172) Comparison of efficacy and safety outcomes between three CDK4/6 inhibitors in HR+/HER2- metastatic breast cancer

(9-173) Development and Impact of a Bariatric Surgery Clinical Pharmacist Program in an Outpatient Clinic Setting

(9-174) Impact of a Pharmacy-Led Discharge Medication Access Program (MAP) at an Academic Medical Center

(9-175) Evaluation of Terlipressin and Norepinephrine in Reversing Hepatorenal Syndrome (HRS)

(9-176) Evaluating the Impact of Pharmacist-Driven Interventions on Appropriateness of Antibiotic Prescribing During Hospitalization and Upon Discharge

(9-177) Impact of Transitions-of-Care (TOC) Pharmacist Post-Discharge Follow-Up in Cancer Transitional Care (CTC) Clinic

(9-178) Optimal Management of Gram-Negative Rod Bacteremia in Hematology and Oncology Patients

(9-179) Impact of Novel Pharmacy Model on Patient Health Outcomes and Satisfaction - An Extended Scope and Result

(9-180) Assessing Concordance of Serum Creatinine and Cystatin C Estimated Glomerular Filtration Rate (eGFR) in Lung Transplant Recipients

(9-181) Safety of Weight-Based versus Fixed Dosing of Phenobarbital for Treatment of Alcohol Withdrawal in the Emergency Department

(9-182) Evaluation of Procalcitonin-Guided Algorithm for Antibiotic Use in Lower Respiratory Tract Infections

(9-183) Efficacy and Safety of High Dose Ketamine for the Treatment of Refractory Status Epilepticus

(9-184) Assessment of Specialty Pharmacist Interventions implemented during prospective drug utilization reviews

(9-185) Evaluating Hypoglycemic Risk Following Treatment of Hyperkalemia: A Pre-Post Study Analysis on the Effect of Reduced Insulin Therapy

(9-186) Impact of Pharmacy Transitions of Care on Heart Failure GDMT Optimization

(9-187) Utilization of Sugammadex in the Operating Room Across a Large Integrated Healthcare System

(9-188) Appropriate Use of Carbapenems

(9-189) Evaluation of Antimicrobial Utilization in Patients Undergoing Extracorporeal Membrane Oxygenation (ECMO)

(9-190) Appropriateness of Initiating Bundled Insulin Order Sets

(9-191) Reducing Expired Medication in Pyxis Inventory at an Academic Medical Center

(9-192) Patient Satisfaction and Self-Reported Understanding with Pharmacist-Led Interventions for Travel Medicine

(9-193) Comparative Analysis of Patient Financial Assistance Programs Amongst Large Academic Medical Centers

(9-194) Preventing Infections in Patients Receiving T-Cell Redirection Therapies: Experience from a Comprehensive Cancer Center

(9-195) Impact of Prior Authorization Removal on SGLT2 Inhibitor Utilization in Patients with Diabetes

(9-196) Initial Assessment of a Community Health Worker Certificate Program Administered to Pharmacy Technicians for Effectiveness and Proof of Concept

(9-197) Impact of Diabetes Education Classes on Patient Retention and Outcomes

(9-198) Evaluation of a Pharmacist-led Vaccine Screening & Consultation Program in Patients with Multiple Sclerosis, Chronic Myelogenous Leukemia, or Chronic Lymphocytic Leukemia

(9-199) Occurrence of serotonin syndrome in linezolid patients: focusing on characteristics of concomitant serotonergic agents

(9-200) Chimeric Antigen Receptor T-Cell Therapy-Related Cytokine Release Syndrome and Neurotoxicity: Real-World Outcomes from a Comprehensive Cancer Center

(9-201) Clinical Outcomes of Long-Acting Injectables in People Experiencing Homelessness

(9-202) Effect of Antipsychotic Initiation on Psychotic Symptoms in Patients Using Stimulants: A Retrospective Chart Review

(9-203) Evaluating the Layered Learning Practice Model’s Impact on Pharmacy Learners’ Clinical Reasoning and Communication Skills in a Transition of Care Rotation

(9-204) Evaluation of pharmacist comfort and readiness for prescribing services for Human Immunodeficiency Virus (HIV) Post-Exposure Prophylaxis (PEP)/ Pre-Exposure Prophylaxis (PrEP) after completing an educational video

(9-205) Assessing the Impact of Education and Electronic Health Record (EHR) Order Modification on Blood Culture Appropriateness in a Community Health System

(9-206) Assessing the Impact of Pharmacist-led Education and Institutional Antimicrobial Stewardship Guidebook Modifications on Daptomycin Utilization in a Community Hospital

(9-207) Evaluating the Effect of a Revised Clinical Scoring Tool in an Electronic Health Record (EHR) on Clinical Pharmacists' Prioritization of Patient Monitoring

(9-208) Evaluation of Treprostinil Practice for Pulmonary Hypertension at a Pediatric Academic Medical Center

(9-209) Magnusiomyces clavatus fungemia treated with combination antifungals including isavuconazole and flucytosine in a pediatric patient with Fanconi anemia and recent umbilical cord blood allogenic transplant

(9-210) Buprenorphine Micro-Induction for Chronic Pain Management in an Adolescent: A Case Report

(9-211) Phenobarbital for Adjunctive Sedation in a Pediatric Patient ​ on Continuous Renal Replacement Therapy

(9-212) Use of perampanel load and maintenance dosing in a 3-year-old with intractable generalized epilepsy in refractory status epilepticus

(9-213) Evaluation of Emapalumab Usage and Safety in Pediatric Patients at a Pediatric Health System: A Medication Utilization Evaluation

(9-214) Code Calm - Enhancing Acute Agitation Management for Pediatric Emergency Settings

(9-215) Continuous Vancomycin v. Intermittent Vancomycin Use in Infants in a Neonatal Intensive Care Unit

(9-216) Incidence of Hypertriglyceridemia in Low Birth Weight Neonates Receiving Intravenous Lipids

(9-217) Assessing Ambrisentan Safety and Usage at Children’s Hospital Colorado (CHCO)

(9-218) In Vitro Analysis of Whole Blood Compatibility with Commonly Used Medications in the Trauma Setting

(9-219) Evaluation of Pain Control in Postoperative Patients Following Intravenous Acetaminophen Formulary Removal

(9-220) Evaluation of Fidaxomicin and Oral Vancomycin Usage in Hospitalized Patients with Severe Clostridioides difficile Infection

(9-221) Evaluation of Rapid Blood Pressure Reduction in Spontaneous Intraparenchymal Hemorrhage

(9-222) Comparison of N-Acetylcysteine Two Versus Three Bags Protocol in Acetaminophen Overdose

(9-223) Evaluation of Complications Related to Glucagon-like Peptide-1 Receptor Agonists in Trauma Surgery Patients

(9-224) Pharmacist Impact on Time to Administration and Appropriate Use of Four-Factor Prothrombin Complex Concentrate

(9-225) Optimizing Time to Therapeutic INR with Warfarin through a Pharmacy to Dose Consult Program: A Retrospective Review

(9-226) A retrospective review of the pre- and post-implementation effects of a pharmacy-driven culture callback program in the emergency department at a community hospital

(9-227) Evaluating the Safety and Efficacy of Pharmacy-to-Dose Vancomycin Protocols in Neonatal Intensive Care Patients

(9-228) Evaluating Utilization of Dornase Alfa Following Pharmacy and Therapeutics Committee Implemented Restriction Criteria

(9-229) Evaluating the Effectiveness of an In-Service Program to Better Educate Providers on Prescribing Clindamycin for Surgical Prophylaxis

(9-230) The Impact of Intravenous to Oral Conversion of Lorazepam after Forty-Eight Hour Hospitalization for Alcohol Withdrawal

(9-231) Evaluating How Pharmacy Students’ Work Experience Influences Their Career Goals

(9-232) Retrospective Assessment of a Novel Venous Thromboembolism Prophylaxis Burn Protocol

(9-233) Evaluation of Inpatient Intravenous Immune Globulin (IVIG) Utilization in the UCHealth Southern Colorado Region

(9-234) Evaluation of Four-Factor Prothrombin Complex Concentrate (4F-PCC) for Direct Oral Anticoagulant (DOAC) Reversal

(9-235) Evaluation of Soybean, Medium-chain Triglyceride, Olive, and Fish Oils Lipid Injectable Emulsion Usage in Custom-Ordered Total Parenteral Nutrition (TPN) Regimens in Hospitalized Patients

(9-236) Evaluation of Albumin Usage and Compliance with Clinical Use Criteria

(9-237) HIT Me with Your Best Clot: A Retrospective Comparison Review of Bivalirudin and Argatroban When Used for Incidences of Suspected or Confirmed Heparin-Induced Thrombocytopenia

(9-238) Clozapine-Induced Myocarditis: A Pharmacist-Driven Intervention

(9-239) Review of Antibiotic Use Trends for Treatment of Skin and Soft Tissue Infections at UCHealth Northern Colorado Hospitals

(9-240) Evaluation of Hemodynamic Goals in Neonatal and Pediatric Patients on Vasopressors

(9-241) Comparative Efficacy of Povidone-Iodine and Antibiotic Irrigation Solutions for the Prevention of Prosthetic Joint Infections in Total Joint Arthroplasty

(9-242) High-Cost Drug Formulary Stewardship: Health System Evaluation of Intravenous Immunoglobulin (IVIG) Utilization

(9-243) Evaluation of Pain Control in Lobectomies: Before and After the Removal of Liposomal Bupivacaine from Formulary at an Academic Health System

(9-244) Evaluation of Racial and Social Disparities in the Empiric Treatment of Sexually Transmitted Infections (STIs) in the Emergency Department

(9-245) Evaluating the Impact of Pharmacist Education and Implementation of a Meds-to-Beds Program Upon Hospital Discharge for Patients with Heart Failure

(9-246) Evaluation of Buprenorphine Continuous Infusions for Analgosedation in the Intensive Care Unit (ICU)

(9-247) Efficacy and Safety of Intravenous Magnesium in Patients with Atrial Fibrillation with Rapid Ventricular Response in an Emergency Department

(9-248) Evaluating The Safety of Pembrolizumab Extended-Interval Dosing Compared to Standard Dosing

(9-249) Evaluation of Early Conversion to Belatacept in Renal Transplant Recipients with Poor Renal Function

(9-250) Evaluation of an embedded 4T scoring clinical decision tool on the assessment and treatment of heparin induced thrombocytopenia (HIT)

(9-251) Impact of Pharmacist Intervention on Direct Oral Anticoagulant (DOAC) Affordability for Adult Anticoagulation Clinic Patients

(9-252) Impact of Pharmacist-Medical Resident Led Transitions of Care Services for Patients in Internal Medicine

(9-253) Implementation of a Critical Care Pharmacotherapy Checklist to Improve Non-ICU Pharmacist Care for Patients in the ICU

(9-254) Evaluation of the Utilization of a Broad-Spectrum Antibiotic Monitoring Tool Across a Large Academic Hospital System

(9-255) Evaluation of the Utilization of a Broad-Spectrum Antibiotic Monitoring Tool Across a Large Academic Hospital System

(9-256) Assessing Ambulatory Surgery Product Control Pathways for High-Cost Medications

(9-257) Impact of antibiotic order sets with integrated recommendations for specific beta lactam drug hypersensitivity reactions and cross-reactivity risk on the utilization of penicillin and cephalosporins

(9-258) Evaluation of Direct Oral Anticoagulation Reversal Agent Utilization at Nuvance Health

(9-259) Evaluating the Accuracy of Prescriber Selected Indications on Antibiotic Orders

(9-260) Evaluating the impact of pharmacist interventions on HgbA1c within a diabetes management program: a retrospective study

(9-261) A Multi- Site Survey of Primary Care Providers’ Perceptions of Implementing Pharmacist Services in a Weight Loss Clinic

(9-262) Use of Preoperative Methadone in Spinal Surgery Patients for Postoperative Pain Control, A Retrospective, Single-Site Cohort Study

(9-263) Evaluation of Heparin-Induced Thrombocytopenia Testing to Improve Anticoagulation Stewardship in an Acute Care Setting

(9-264) Safety and efficacy of warfarin versus direct oral anticoagulants for management of post-coronary artery bypass grafting atrial fibrillation

(9-265) Evaluation of Intravenous and Oral Magnesium Replacement in the Critically Ill Patient

(9-266) Impact of Patient Specific Factors on the Efficacy of Immune Checkpoint Inhibitors in Advanced Non-Small Cell Lung Cancer

(9-267) Evaluating the Safety of Peripherally Administered Vasopressors Based on a System-Side Protocol in a Healthcare System

(9-268) Impact of Pharmacist Intervention during Transitions of Care on Readmission Rates in Stroke Patients Enrolled in Meds 2 Beds Program

(9-269) Desmopressin Efficacy and Safety in Traumatic Intracranial Hemorrhage Patients on P2Y12 Inhibitor Antiplatelet Therapy

(9-270) Heartfelt Insights: Identifying Opportunities to Modify Cardiovascular Risk Factors in Inflammatory Arthritis Management

(9-271) Impact of Pharmacist Intervention on Increasing Adult HPV Vaccination Rate in an Outpatient Internal Medicine Clinic

(9-272) Assessing the Frequency and Effects of Inappropriate Direct Oral Anticoagulant Prescribing in Outpatient Discharge

(9-273) Swab, Analyze, Optimize: The Impact of Pharmacist-Led MRSA Swab Screening Policy on Vancomycin Use

(9-274) Impact of Scheduled Acetaminophen on the Management of Antibiotic Therapy in Surgical Patients with Suspected Bacterial Infections

(9-275) Gap Analysis Evaluating Direct Oral Anticoagulant Monitoring in a Community Hospital Compared to Anticoagulation Forum Standards

(9-276) Evaluation of Opioid Usage Post Formulary Removal of Liposomal Bupivacaine in Cesarean Section

(9-277) Evaluation of broad-spectrum antibiotic monitoring tool use across a large academic hospital system

(9-278) Creation of Rapid Access Pathway to Outpatient Care for High-Cost Biologics in an Academic Health System

(9-279) Identifying Opportunities to Utilize Artificial Intelligence to Improve Efficiency and Accuracy of Medication Reconciliation through Different Phases of Care

(9-280) Assessment of custom task use within the electronic medical record to optimize a specialty pharmacy and ambulatory care integrated workflow

(9-281) A Medication Use Evaluation of Alternative Rifaximin Dosing in an Inpatient Setting at an Academic Medical Center

(9-282) A Retrospective Medication Use Evaluation of Bivalirudin

(9-283) Evaluation of Anti-Inhibitor Coagulant Complex Usage Relative to Health System Guidelines and Current Clinical Practices

(9-284) Evaluation of broad-spectrum antibiotic monitoring tool use across a large academic hospital system

(9-285) Evaluation of current sterile products waste practices and development of standardized protocol across a Five Hospital Health System

(9-286) Evaluation of Pain Management: Comparative Analysis of Liposomal Bupivacaine versus Alternative Anesthetics for Bunionectomy

(9-287) Optimizing Darbepoetin Utilization: A Prospective Medication Use Evaluation to Reduce Inappropriate Use and Achieve Cost Savings

(9-288) Three Cheers for Stewardship: A Retrospective Medication Use Evaluation of Antithrombin III

(9-289) Proactive Automation of Medication Therapy Monitoring and Continuous Maintenance Through Use of Artificial Intelligence

(9-290) The Implementation of Artificial Intelligence Automation for Intravenous to Enteral Therapeutic Conversion

(9-291) Evaluation of Opioid Prescribing and Multimodal Analgesia in Breast Reconstruction Surgery Patients Before and After Removal of Liposomal Bupivacaine in an Academic Health System

(9-292) Evaluation of Postoperative Pain Control and Multimodal Analgesia with Liposomal Bupivacaine in Patients Undergoing Total Shoulder Arthroplasty

(9-293) Assessment of effective communication methods in the ambulatory care setting

(9-294) Evaluation of opportunities for communication standardization between ambulatory care pharmacy and health system-based community pharmacies

(9-295) Identification of electronic health-record enabled communication best practices to address patient concerns from ambulatory care pharmacy technicians to clinical pharmacists.

(9-296) Incidence of Hypophosphatemia in Pediatric Diabetic Ketoacidosis

(9-297) Evaluation of vaccination compliance in infants admitted to the neonatal intensive care unit and cardiac center

(9-298) Clinical Utility of Methicillin Resistant Staphylococcus Aureus (MRSA) Nares Swabs in Guiding Antimicrobial Therapy in Pediatric Patients

(9-299) Retrospective Comparison of Standard Premix Total Parenteral Nutrition Versus Custom Total Parenteral Nutrition in Hospitalized Patients: Assessing Cost Effectiveness and Clinical Outcomes

(9-300) Assessing Compliance with Revised Creatine Kinase Monitoring Guidelines for Intravenous Daptomycin

(9-301) Evaluation of Sodium Bicarbonate Continuous Infusions at a Single-Center Hospital

(9-302) Impact of Pharmacist on Time to Tissue-Type Plasminogen Activator Administration in Patients with Acute Ischemic Stroke

(9-303) Medication Use Evaluation of Beyfortus® (Nirsevimab-alip) in Neonatal and Pediatric Patients

(9-305) Evaluation of Tolvaptan Use in Hyponatremia Management: Adherence to Criteria and Clinical Outcomes

(9-306) Cutting Pharmacy Waste: Establishing a Process to Streamline Excess Medication Sharing

(9-307) Correlation of 4T score, m4T, and LLL with Positive Heparin Antibodies and Serotonin Release Assays (SRAs) in Cardiac Surgery ICU Patients

(9-308) Evaluation of Protamine Dosing Strategies Following Cardiopulmonary Bypass

(9-309) Evaluation of Safety and Efficacy of Venous Thromboembolism Prophylaxis with Unfractionated Heparin versus Enoxaparin in Obese Patients

(9-310) Guideline Directed Medical Therapy Prescribing and Safety in Patients with Acute Decompensated Heart Failure

(9-311) Efficacy of Balanced Solutions versus Normal Saline on Diabetic Keto-acidosis Resolution

(9-312) Impact of a (1,3)-β-D-Glucan-based Treatment Algorithm on Empiric Micafungin Duration of Therapy in Critically Ill Patients

(9-313) The Impact of Empiric Linezolid Compared to Vancomycin on Inpatient Outcomes

(9-314) Evaluation of Appropriateness of Antibiotics Prescribed at ED Discharge for Urinary Tract Infections or Community Acquired Pneumonia in Medicare Patients 65+

(9-315) Impact of Concomitant Antibiotic Use on Treatment Outcomes in Patients with Clostridioides difficile Infection Receiving Fidaxomicin

(9-316) Assessment of Infusion Reaction Rates with Day 1 administration vs Day 5 Administration of Rituximab or biosimilars in Dose-adjusted R EPOCH

(9-317) Comparison of Dostarlimab to Pembrolizumab in Combination with Chemotherapy in Patients with Advanced or Recurrent Endometrial Cancer

(9-318) Evaluate the use of fluconazole in patients with candiduria

(9-319) Medication Use Evaluation of Cefepime-Induced Neurotoxicity

(9-320) Evaluating the Use of Clevidipine for In-Patient Adults

(9-321) The Impact of Pharmacist Discharge Education in Preventing Acute Heart Failure Rehospitalizations

(9-322) Simplified Phenobarbital Versus Benzodiazepine Driven CIWA-Ar Protocol in ICU or ED for Alcohol Withdrawal Syndrome

(9-323) Evaluating Pharmacists’ Impact on Fiscal Outcomes, Chronic Disease Management, and Care Quality through Analysis, Interpretation, and Reporting of Continuous Glucose Monitoring Data in Diabetes Management

(9-324) Assessment of the Safety and Efficacy of Therapeutic Enoxaparin vs. Unfractionated Heparin in the Renally Insufficient

(9-325) Comparative Effects of Initial Midodrine Dosing Strategies on Norepinephrine Discontinuation in the Intensive Care Unit

(9-327) Less is More? A Retrospective Comparison of Twice and Thrice Daily Dosing of Metronidazole in Confirmed Anaerobic Infections.

(9-328) Utility of Methicillin-resistant Staphylococcus Aureus (MRSA) Nasal PCR in Guiding Empiric Antibiotics in SSTIs

(9-329) 4-Factor Prothrombin Complex Concentrate Medication Use Evaluation for the Reversal of Oral Anticoagulants at Ascension St. Vincent’s Facilities

(9-330) Adjunctive Use of Dexmedetomidine for Treatment of Alcohol Withdrawal in the Intensive Care Unit (ICU)

(9-331) Enhanced Recovery After Surgery vs non-Enhanced Recovery After Surgery: post-operative pain control review

(9-332) Ascension St. Vincent’s Healthcare Medication Use Evaluation (MUE) to Assess Appropriateness of Carbapenem Use in Urinary Tract Infections (UTI)

(9-333) Medication Use Evaluation (MUE) for Comparison of Area Under the Curve (AUC) vs Trough Dosing Protocols for Vancomycin

(9-334) Evaluation of Clinical Pharmacist Intervention in a FQHC Setting Using Selected HEDIS Measures

(9-335) Pharmacist-Led Intervention to Increase Human Immunodeficiency Virus Pre-Exposure Prophylaxis Use in a Federally Qualified Health Center Setting

(9-336) A Retrospective Evaluation of Real-Time, Nurse-Directed Clinical Decision Support Alerts for aPTT Results and Heparin Titration: Impact on Timely Heparin Adjustments in a Nurse-Managed Protocol

(9-337) Modifiable Causes of Heart Failure Readmissions at a Community Health Care System

(9-338) Impact of a Pharmacy Centralized Distribution Center on Health System Reliability, Compliance & Optimization

(9-339) Medication Use Evaluation of Tirzepatide FDA Approved for Type 2 Diabetes in the Outpatient Setting

(9-340) Medication Use Evaluation on Apixaban in Patients with Venous Thromboembolism

(9-341) Multi-center, Retrospective Evaluation of Every 8-hours versus Every 12-hours Metronidazole Dosing for Intra-Abdominal Infections

(9-342) Retrospective Evaluation of Adherence, Discontinuation, and Readmission Rates following Inpatient Administration of a Second-Generation Long-Acting Injectable Antipsychotic.

(9-343) Evaluation of cangrelor prescribing trends across an acute care health-system

(9-344) Evaluation of Direct Oral Anticoagulants in Comparison to Vitamin K Antagonists in the Management of Left Ventricular Thrombus

(9-345) Retrospective Analysis of Antiepileptic Drug Loading Doses in Status Epilepticus

(9-346) Evaluation of Parenteral Nutrition Management in Adult Hospitalized Patients

(9-347) Evaluation of Intravenous Iron Sucrose Use at a Multi-Site Cancer Center

(9-348) Optimal Duration of Insulin Post-Open-Heart Surgery

(9-349) Impact of Dalbavancin on Hospitalization Rates for Cellulitis

(9-350) Effect of Intravenous Phenobarbital on Direct Bilirubin Levels in Neonatal Cholestasis

(9-351) Retrospective Study on Sleep Maintenance, Sleep Onset and Treatment Tolerability: Other Agents vs Melatonin in Pediatric Psychiatry

(9-352) Comparison of 8 versus 15 Days of Antibiotic Therapy for Hospital-Acquired Pneumonia in Adult Intensive Care Unit Patients

(9-353) Impact of iron administration in iron deficient patients with heart failure with reduced ejection fraction.

(9-354) Ceftriaxone dosing in obese patients with bacteremia

(9-355) Influence of Automatic Prescription Dispensing Machine Inventory Management and Antimicrobial Stewardship on Antimicrobial Prescribing in Urgent Care Centers

(9-356) Assessing the Implementation of a Pharmacist-Driven Home Medication Reconciliation in Admitted Surgical Patients

(9-357) Effectiveness of Andexanet versus 4-Factor Prothrombin Complex Concentrate for Factor Xa Inhibitor-Associated Acute Intracerebral Hemorrhage

(9-358) Implementation of a Pilot Pharmacist-Led Medication Therapy Management Clinic to Assess Feasibility and Acceptability

(9-359) Acetazolamide versus Metolazone in Acute Heart Failure

(9-360) Comparison of beta-blocker use to no beta-blocker use in patients with traumatic brain injury at two urban trauma centers

(9-361) Levetiracetam Prophylaxis vs. no Antiseizure Medication Prophylaxis in Patients with Mild Traumatic Brain Injury at a Level 1 Trauma Center

(9-362) Use of Factor Products in Cardiac Surgery-Related Hemorrhage

(9-363) Assessment of Heart Failure Guideline-Directed Medical Therapy Adherence and Barriers to Use in Cardiology and Primary Care Clinics

(9-364) Assessment of Fluid Sensitive Patient Populations After Fluid Resuscitation in the Setting of Sepsis

(9-365) High vs Low Dose Systemic Steroids for Acute Exacerbations of COPD: A Cost/Safety Analysis

(9-366) Evaluation of Treatment Approaches for ACEis/ARBs Induced Angioedema: Standard Allergy Protocol Compared to Tranexamic Acid and/or C1-Esterase inhibitors and/or Fresh Frozen Plasma

(9-367) Evaluation of Efficacy and Safety of Droperidol for the Relief of Acute Migraine Headaches Versus Metoclopramide

(9-368) Evaluation of Oral Fosfomycin Treatment Outcomes in Patients with Pseudomonas aeruginosa-Associated Urinary Tract Infections

(9-369) Impact of Early Oral Step-Down in Urinary Tract Infections Caused by ESBL-producing Enterobacterales

(9-370) Evaluation of Pharmacist and Prescriber Compliance with naloxone and Schedule II Opioid Prescriptions in South Florida Community Pharmacies and the Potential Impact of Pharmacist Intervention

(9-371) The Benefits of Pharmacists Offering Test-and-Treat Services in Community Pharmacies

(9-372) Mentorship, Organizational Support, and Retention: A Study on Pharmacy Internship Outcomes

(9-373) Factors Contributing to Decreasing Enrollment in Pharmacy School

(9-374) Evaluating the Efficacy of Telehealth for Pharmaceutical Care in Pharmacy Deserts without Community Pharmacists

(9-376) Impact of Pharmacist-led Interventions on A1c Reduction using Continuous Glucose Monitoring in Uncontrolled Diabetes within a Federally Qualified Health Center Setting

(9-377) Impact of Pharmacist-Led Interventions on Patients Out of Range Blood Pressure at Federally Qualified Health Center

(9-379) The Evaluation of the Meropenem Protocol in HCA Florida Aventura Hospital

(9-380) Pharmacy Directed Dosing of Epoetin Alfa in Hospitalized Patients with Anemia of Chronic Kidney Disease or End-Stage Renal Disease

(9-381) Safety and Efficacy of Phenobarbital versus Benzodiazepines for Patients with Alcohol Withdrawal Syndrome in Hospitalized Patients

(9-383) Optimizing Antibiotic Discontinuation during Neonatal Sepsis Evaluation

(9-384) Comparison of Prothrombin Complex Concentrate, Human, to Prothrombin Complex Concentrate, Human-Lans, for Reversal of Direct Oral Anticoagulants

(9-385) Impact of Computerized Provider Order Entry on the Adherence of Guideline-Directed Medical Therapy for Urgent Therapy Antiepileptics in Status Epilepticus

(9-386) Nursing-driven analgosedation management in patients on extracorporeal life support (ECLS) during day versus night shifts: medication use evaluation (MUE)

(9-387) Opioid Stewardship at HCA Florida Largo Hospital. Medication Use Evaluation (MUE).

(9-388) Assessing Clinical Outcomes with Thiamine as a Therapeutic Adjunct for Septic Shock in a Community Hospital Intensive Care Unit: A Pre and Post Observational Study.

(9-390) Potassium Response to Sodium Polystyrene Sulfonate versus Sodium Zirconium Cyclosilicate for Treatment of Asymptomatic Hyperkalemia in Emergency Department Patients

(9-392) Comparison of Clinical Outcomes Following Implementation of a New Diabetic Ketoacidosis Protocol

(9-393) Evaluating Sugammadex Vial-Splitting as a Cost-Savings Initiative

(9-394) Opioid Consumption: The Impact of Revisions to an Inpatient Opioid Order Set

(9-395) Cost-Benefit Analysis of Inpatient Penicillin Allergy Assessment

(9-396) Unraveling Allergies: Evaluating the Impact of a Penicillin Allergy Clarification Service

(9-397) Impact of Patient Preference on Inpatient Analgesia

(9-398) Impact of Midodrine Use to Wean Patients off Vasopressors Experiencing Shock

(9-399) Evaluation of Discharge Prescriptions for Uncomplicated Cystitis in the Emergency Department

(9-400) Gadopiclenol Use in Cardiovascular Morphology and Function in Magnetic Resonance Imaging

(9-401) Using the Institute for Healthcare Improvement (IHI) Model for the Implementation of a Naloxone Take-Home Kit (NTHK) Program for Patients Discharged from a Healthcare Institution

(9-402) High-dose furosemide diluted in hypertonic saline versus loop diuretics administered in conjunction with albumin: a comparison of diuretic response in critically ill patients

(9-403) Outcomes of Intra-operative Administration of Recombinant Factor VIIa Versus Four Factor Prothrombin Complex Concentrate in Cardiothoracic Surgery Patients

(9-404) Clearing the Air: Antibiotic Use and Outcomes in COPD Exacerbations

(9-405) Iron Sucrose Compared to Sodium Ferric Gluconate Complex: A Retrospective Analysis of Adverse Reactions in Obstetrics and Hospitalized Patients

(9-406) The Role of Pharmacist Follow-Up Calls in Addressing Medication-Related Problems

(9-407) Evaluating the Impact of Pharmacist Led Heparin Infusion Monitoring

(9-408) Enhancing glycemic control post implementation of a clinical surveillance program.

(9-409) Short versus Long Duration of Treatment for Gram-Negative Bacteremia in a Community Hospital

(9-410) Evaluation and Optimization of Early Parenteral Nutrition in Very Low Birth Weight Infants

(9-411) Utilization of Lipid Fat Emulsion in Bone Marrow Transplant Patients

(9-412) Evaluation of Methylene Blue in Adult Patients with Vasopressor Resistant Vasodilatory Shock

(9-413) Droperidol Use in the Emergency Department

(9-414) Linezolid Use in a Large Academic Medical Center’s Emergency Department

(9-415) Evaluation of ketorolac use in the post-orthopedic surgery population

(9-416) Time to venous thromboembolism prophylaxis in patients with nontraumatic spontaneous intracerebral hemorrhage

(9-417) Comparison of Pharmacist-Driven Vancomycin AUC-over-MIC Therapeutic Drug Monitoring versus Traditional Vancomycin Trough Monitoring in a Community Teaching Hospital

(9-418) Evaluation of Albumin Duration of Therapy and Indication in a Community Health System

(9-419) Evaluation of Benzodiazepine and Antiepileptic Drug Utilization in Emergency Department Patients with Status Epilepticus: Impact on Airway Protection and Treatment Outcomes

(9-420) Impact of Pharmacist-Led Interventions on Aztreonam Utilization in Adult Patients in a Community Healthcare System

(9-421) Prophylactic antibiotic use for traumatic maxillofacial fractures at a Level II trauma center

(9-422) Evaluation of Pediatric Restricted Antimicrobial Orders

(9-423) Antibiotic Utilization in Free Standing Emergency Departments

(9-424) Tranexamic Acid Medication Usage Evaluation

(9-425) Daptomycin Dosing Strategy for Obese Patients with Staphylococcus or Enterococcus Bacteremia: Total Body Weight versus Adjusted Body Weight

(9-426) Impact of fidaxomicin vs. vancomycin on 30-day readmission rates in the treatment of patients with first episode of Clostridioides difficile Infection

(9-427) Comparing Bleeding Events in Underweight Patients Receiving Standard Versus Reduced Dosing of Enoxaparin for Venous Thromboembolism Prophylaxis

(9-428) Continuation Rate of Antipsychotics at Discharge When Initiated for Intensive Care Unit Delirium

(9-429) Evaluating the Impact of an Inpatient Pharmacist-Driven Glycemic Control Management Program in Noncritical Adults with Type 2 Diabetes Mellitus

(9-430) Evaluating the Role of Glucagon-Like-Peptide-1 Receptor Agonists as Adjunctive Therapy for Suboptimal Weight Loss Following Bariatric Surgery

(9-431) Leveraging an Algorithmic Approach to Enhance Inventory Management and Minimize Costs within an Acute-Care Pharmacy setting

(9-432) Evaluation of Initial Diuretic Dosing in Diuretic-Naive Patients with Acute Heart Failure

(9-433) Incidence of Post-Procedural Euglycemic Diabetic Ketoacidosis in Hospitalized Adults with Heart Failure and Pre-Procedural Use of Dapagliflozin

(9-434) Impact of Pharmacist-Led Medication Review at Discharge on High-Risk Medicare Patients

(9-435) Evaluation of Bivalirudin Titration Protocol in Patients With Temporary Heart Pumps

(9-436) Impact of Nimodipine Dosing Variations on Neurological Recovery and Cerebral Vasospasm Incidence

(9-437) Impact of Bridge Therapy on Sedation and Analgesia Requirements in Intubated Patients

(9-438) Optimizing Pharmacotherapy for Suicidal Ideation: An Evaluation of Appropriate Initiation Strategies at Memorial Regional Hospital

(9-439) Retrospective Evaluation of the Appropriateness of Pharmacological Intervention for Agitation in Elderly Hospitalized Patients

(9-440) Evaluation of Outcomes Associated with Parenteral Anticoagulation Followed by Full Initial Dosing of Apixaban or Rivaroxaban in Newly Acute VTE Patients

(9-441) Impact of Loop Diuretic Initial Dosing Strategy on Hospital Length of Stay in Patients with Heart Failure

(9-442) Evaluating Time to Treatment of Tenecteplase vs Alteplase for In-Hospital Acute Ischemic Stroke

(9-443) Fentanyl Bolus Dosing Versus Continuous Infusion for Analgosedation in Mechanically Ventilated Patients

(9-444) The Effect of Beta-Blocker Use in Pregnancy on Hypoglycemia Events in Neonates During Hospital Stay

(9-445) The Use of Procalcitonin on the Reduction of Antibiotic Duration in Sepsis and Septic Shock Following a Health System Initiative; a Pre-Post Evaluation

(9-446) Impact of Multidisciplinary Interventions on Sepsis Outcomes: A Pre- and Post-Implementation Analysis

(9-447) Safety Outcomes of Aromatase Inhibitor Therapy in Breast Cancer Patients Across Different Racial Backgrounds

(9-448) Comparison of Peak Anti-Xa Levels After the Second and Third Administrations of Enoxaparin

(9-449) Intermittent versus Continuous Albuterol Administration in Patients with Status Asthmaticus in the Emergency Department

(9-450) Retrospective Review of Cephalexin Dosing Strategies in Pediatric Urinary Tract Infections

(9-451) Comparing PANSS Score Placebo-Subtracted Reduction in a Mechanistically Novel Antipsychotic Compared to Previous Typical and Atypical Antipsychotics

(9-452) Utilization of Electrolyte Replacement Protocol

(9-453) Tenecteplase Versus Alteplase in Ischemic Stroke

(9-454) Evaluation and Comparison of an Artificial-Intelligence Software vs Manual Data Analysis and its Impact on the Detection and Resolution of Diversion

(9-455) Assessing Time to Optimal Antibiotic Treatment for Blood Stream Infections After Initiation of Blood Cultures Identification Panel at a Community Teaching Hospital

(9-456) The Impact of Clinical Pharmacist on The Success Rate of Prior Authorizations Approval: A Retrospective Study

(9-458) Evaluation of Antibiotic Duration in Cellulitis and Abscess Treatment

(9-459) Duration of Seizure Prophylaxis in Moderate to Severe Traumatic Brain Injury Requiring Neurosurgical Intervention

(9-460) Targeting optimal sedation during targeted temperature management (TOS-TTM)

(9-461) Impact of a Clinical Decision Support Tool on Testing and Diagnosis of Heparin-Induced Thrombocytopenia in a Large Community Hospital

(9-463) Evaluating the Impact of a Second Medication History Performed by a Pharmacy Extender at an Acute Inpatient Behavioral Health Hospital

(9-464) Impact of Pharmacist-Led Rounds in the Intensive Care Unit to Oversee Non-Pharmacological Delirium Prevention at an Acute Care Hospital

(9-465) Use of Amiodarone, Diltiazem, or Metoprolol for Rate Control in Patients with Atrial Fibrillation and Heart Failure with Reduced Ejection Fraction in the Emergency Department

(9-466) Evaluation of Electrolyte Replenishment Orders across a Multi-Hospital Health System

(9-467) Comparing Prophylactic Amiodarone Versus No Amiodarone for the Prevention of Postoperative Atrial Arrhythmias in Cardiothoracic Surgery Patients

(9-468) Assessment of Polypharmacy in the Elderly Population at a Community Hospital: An Observational Cohort Study

(9-469) An Evaluation of Drug-Disease Interaction Alerts in Medication-related Clinical Decision Support (mCDS)

(9-470) Evaluating the Efficacy and Safety of Enoxaparin Dosing for Venous Thromboembolism Prophylaxis in Low Body Weight Patients

(9-471) Evaluation of Alvimopan in minimally invasive procedures using ERAS

(9-472) 30-Day Readmission due to Gastrointestinal Bleeding: Comparing Twice-Daily Dosing versus Continuous Infusion of Pantoprazole

(9-473) Acute pain in opioid-naïve patients: evaluating morphine dosing strategies in the emergency department

(9-474) Acetaminophen versus High Dose Ibuprofen in Preterm Infants with Patent Ductus Arteriosus: A Retrospective Non-Inferiority Trial

(9-476) Comparison of Furosemide and Metolazone Based Regimens to Furosemide Drip in Acute Heart Failure

(9-477) Effect of Abdominal Wall Thickness on Anti-Xa Levels During Enoxaparin Prophylaxis in Obese Trauma Patients

(9-478) Comparing the impact of aprepitant injectable emulsion to antiemetic standard of care on post operative nausea and vomiting following bariatric surgery

(9-479) Evaluating the Impact of Haloperidol and Droperidol in Treatment of Cannabinoid Hyperemesis Syndrome (CHS) in the Emergency Department

(9-480) Optimizing Low-Density Lipoprotein Cholesterol Management in Atherosclerotic Cardiovascular Disease Patients: A Pharmacist-Physician Collaborative Protocol

(9-481) Administration of Droperidol, Haloperidol, or Ondansetron for Nausea Management in Emergency Department Patients

(9-482) Assessing Patients’ Awareness and Utilization of Pharmacy Services in Independent Community Pharmacy Settings

(9-483) Evaluation of Risk Index for Overdose or Serious Opioid-Induced Respiratory Depression (RIOSORD) and Opioid-Related Adverse Reactions in the Inpatient Setting

(9-484) Evaluation of Extravasation with Peripheral Norepinephrine Administration

(9-485) Evaluation of remote clinical interventions within a healthcare system: a quality improvement project

(9-486) Optimization of Evidence-Based Order Sets to Reduce Duplicate Medication and Drug-Drug Interaction Alerts and Alleviate Alert Fatigue in Pharmacists

(9-487) Evaluating the Impact of Pharmacist-Led Transitions of Care Interventions on 30-Day Hospital Readmissions

(9-488) Risk Factors of Patients Who Demonstrated Hemorrhagic Conversion Following Tenecteplase Administration for Acute Ischemic Stroke: a Case-Control Study

(9-489) Benzodiazepine versus Non-benzodiazepine for Sedation in Mechanically Ventilated Patients in the Emergency Department

(9-490) Differences in Vancomycin Duration of Therapy Based on Minimum Inhibitory Concentration Breakpoints in Cases of Non-Methicillin-Resistant Staphylococcus Aureus Gram-Positive Bacteremia

(9-491) Assessing the Effectiveness of Tranexamic Acid in Angiotensin-Converting Enzyme Inhibitor-Induced Angioedema

(9-492) Comparison of 24 versus 72 Hours of Scheduled Intravenous Acetaminophen on Opioid Use after Cardiac Surgery in Pediatric Cardiovascular Intensive Care Unit

(9-493) Impact of Pharmacy-Driven Multimodal Stewardship Interventions on Linezolid Use for Pneumonia

(10-001) Evaluation of a Pharmacist-Driven Erythropoiesis-Stimulating Agent Management Protocol for Anemia in Chronic Kidney Disease

(10-002) Evaluation of Pharmacist-Led Opioid Stewardship Efforts in a Community Hospital

(10-003) Optimizing Outpatient Parenteral Antibiotic Therapy (OPAT): Impact of Continuous Infusion Beta-Lactams and Vancomycin on Patient Adherence and Clinical Outcomes

(10-004) The Clinical Puzzle of Anaerobic Bacteremia: Unpacking Traits of Infections and Patients with Anaerobic Bloodstream Infections and Characteristics of Optimal Therapy

(10-005) Identification of Improvements to Pediatric Medication Safety Through Evaluation of Electronic Health Record Safety Mechanisms in the Emergency Department of an Adult Community Hospital

(10-006) Evaluation of Guideline-Directed Medication Therapy Prescribing of GLP-1 Agonists and SGLT2 Inhibitors in Type Two Diabetic Patients With or at High-Risk of Atherosclerotic Vascular Disease

(10-007) Intravenous Immunoglobulin Use at a Stand-Alone Children’s Hospital

(10-008) Angioedema Resolution: Comparison of Low Dose to High Dose Steroids

(10-009) Efficacy and Safety of Bivalirudin Compared with Heparin Anticoagulation in Critically Ill Patients Requiring Venovenous Extracorporeal Membrane Oxygenation

(10-010) Efficacy of Olanzapine versus Quetiapine for ICU Related Agitation and Delirium

(10-011) Evaluating the Use of Angiotensin II vs. Methylene Blue in Management of Shock in Patients with Liver Failure

(10-012) Combating Resistant Pathogens: Exploring the Efficacy of Eravacycline Utilization in Multidrug-Resistant Infections

(10-013) Optimizing Metronidazole Administration: A Comparative Analysis of Every 12 Hours Versus Every 8 Hours Dosing for Anaerobic Infections

(10-014) Impact of clinical pharmacy team intervention on naloxone fills in patients on chronic opioid therapy

(10-015) Evaluating the Impact of “On the Spot” – a Remote Pharmacy Hypertension Consult Service

(10-016) What Medications Are Most Prescribed but Never Filled? Predictors of Nonadherence in Medicare 5-Star Population

(10-017) Evaluation of Hospital Readmission Rates on Patients Who Completed Medication Reconciliation With A Transitions Of Care Clinical Pharmacy Specialist (CPS) Versus Those Who Did Not

(10-018) Evaluation of a Hypercalcemia Protocol in Hospitalized Patients

(10-019) Evaluating Antiretroviral Formulary Utilization at a Large Academic Medical Center

(10-020) Evaluating the Use of Anaerobic Antimicrobial Use in Therapeutic Treatment of Aspiration Pneumonia

(10-021) Review of the Appropriateness of Empiric IV Acyclovir for Meningitis

(10-022) Comparing Vancomycin Doses to Therapeutic Trough Levels in Pediatric Patients

(10-023) Retrospective Review of Treatment of Acute Chemotherapy-induced Nausea and Vomiting in Pediatric Patients

(10-024) Evaluation of Antibiotic Duration at Hospital Discharge at Northeast Georgia Medical Center

(10-025) Evaluation of the Impact of a Pharmacist-led Smoking Cessation Clinic Within a Primary Care Setting

(10-026) Optimizing Stress Ulcer Prophylaxis in Critically Ill Patients: A Pharmacist-Driven Approach to Discontinuation

(10-027) Evaluation of Four Factor Prothrombin Complex (Kcentra®) Use at a Tertiary Care Medical Center

(10-028) Evaluation of Intravenous Sotalol Loading for Treatment of Atrial Arrhythmias

(10-029) Evaluation of Terlipressin Use in Hepatorenal Syndrome

(10-030) Evaluation of Direct Oral Anticoagulant Utilization for Venous Thromboembolism Treatment in Obese Spinal Cord Injury Rehabilitation Patients

(10-031) Effects of Tramadol on Seizure Incidence in Traumatic Brain Injury Rehabilitation Inpatients

(10-032) Pharmacist-Led Interventions to Improve Adherence and Patient Access to Rifaximin in the Treatment of Hepatic Encephalopathy

(10-033) Evaluating the Efficacy of a Standardized Diuretic Order Panel versus Provider-Prescribed Diuretic Dosing in Acute Decompensated Heart Failure

(10-034) Impact of Dapagliflozin Versus Empagliflozin on Renal Function and Diuretic Response in Patients with Acute Decompensated Heart Failure at a Tertiary Care Community Teaching Hospital.

(10-035) Safety of Initial Fluid Bolus in Overweight and Obese Patients with Sepsis in the Emergency Department: A Retrospective Review

(10-036) Impact of a Pharmacist-Led Glycemic Management Consult Service in Hospitalized Patients

(10-037) Pharmacist Management and Monitoring of Rivaroxaban at a Community Teaching Hospital

(10-038) Pharmacist Management and Monitoring of Apixaban at a Community Teaching Hospital

(10-039) Survey of Healthcare Professionals’ Satisfaction and Perceived Impact on Quality of Care with Pharmacy Pain Management Services

(10-040) Evaluation of Remdesivir Use in COVID-19

(10-041) Evaluation of Cefepime Dosing and Neurotoxicity in Hospitalized Patients: A Medication Use Evaluation at Wellstar Kennestone Regional Medical Center

(10-042) Assessment of an AST/ALT Ratio for Predicting Clinical Recovery After Acetaminophen Poisoning

(10-043) Evaluation of Clinical Outcomes After Expansion of Ambulatory Pharmacist Services to Augusta University Care Center (AUCC) Primary Care Clinics

(10-044) Vancomycin Area Under the Curve Target Attainment Within 24 Hours of Therapy Initiation Following Implementation of a Front-Loading Dosing Strategy

(10-045) Developing an Interprofessional Workflow to Address The Needs of Native Hawaiian Patients with Methamphetamine Associated Cardiomyopathy

(10-046) Exploring Patient Perceptions and Willingness to Receive Botulinum Toxin in Community Pharmacies

(10-047) Implementation of a Treatment Algorithm for Patients with Suspected Heparin-Induced Thrombocytopenia (HIT) at a Tertiary Care Center

(10-048) Advancing Chemotherapy Workflow: A Safety and Efficiency Initiative with Intravenous Workflow Systems and Closed System Transfer Devices

(10-049) Inappropriate Use of Inhaled Corticosteroids (ICS) in Patients with Chronic Obstructive Pulmonary Disease (COPD)

(10-050) Evaluation and Optimization of Practices Surrounding Treatment of Migraines and Complications of Migraine Attacks in an Emergency Department Setting

(10-051) Over-treating UTIs or Do We Comply? Review of Antimicrobial Prescribing for Urinary Tract Infections in a Community Hospital Emergency Department

(10-052) Assessment of a Two-Bag Fluid Protocol for Diabetic Ketoacidosis Treatment in a Community Health System

(10-053) Impact and Management Patterns of Coagulase-Negative Staphylococcus Bloodstream Infections within a Community Health System

(10-054) Pharmacist Time and Cost Analysis of Linezolid versus Vancomycin for Pneumonia at a Community Health System

(10-055) Predicted Benefit of Implementing a Cardio-oncology Pharmacist

(10-056) Evaluation of Pharmacist Role in Improving Continuity of Care for Patients Receiving Long-Acting Injectable (LAI) Antipsychotics

(10-057) Updates on Inhaler Therapeutic Substitution Procedure and Guidance on Pharmacist Prescribing of Reliever Inhalers for SLHS Outpatient Pharmacies

(10-058) Development and Implementation of the Administration of Long-Acting Injectable Antipsychotic (LAIA) Medications in the Setting of an In-Clinic Pharmacy

(10-059) Evaluation of Clinical Outcomes with Cefdinir Versus Other Oral Cephalosporins for Outpatient Pediatric Urinary Tract Infections

(10-060) Improving Community Awareness and Accessibility of Opioid Reversal Agents through Outpatient Pharmacist Education: A Quality Improvement Project

(10-061) Retrospective Comparison of Combined Nebulized and Intravenous Tranexamic Acid for Post Tonsillectomy Bleeding Versus Nebulized or Intravenous Alone in Emergency Department Patients

(10-062) Efficacy and Safety of Sacubitril-Valsartan in Patients with Heart Failure: A Post-ACEi/ARB Switch Study

(10-063) Evaluation of Higher Dose Enoxaparin for Venous Thromboembolism Prophylaxis in Patients with a Body Mass Index > 40

(10-064) Increasing the Presence of Emergency Medicine Pharmacists in the Management of Sepsis

(10-065) Optimizing Medication Histories: Evaluating Pharmacist Workflow and Education for Improved Accuracy

(10-066) Analysis of Predictors for Treatment Outcomes for Patients Enrolled in a Medication for Opioid Use Disorder Program at a Community Health Center

(10-067) Evaluation of Antibiotic Prescribing for Acute Upper Respiratory Infections at a Community Health Center by an Expanded Antimicrobial Stewardship Team

(10-068) The Effect of Adjunct Hydrocortisone and Fludrocortisone Combination Therapy Compared to Hydrocortisone Monotherapy in Patients with Refractory Septic Shock

(10-069) Use of Methylene Blue in Refractory Shock and its Impact on Vasopressor Requirements

(10-070) Infectious Disease Resident Collaboration with Care Management to Expedite Discharge for Patients Prescribed “High-Risk” Intravenous Antimicrobials for Outpatient Administration

(10-071) Evaluation of High-Dose Gabapentin Load and Taper Versus Lorazepam Symptom-Triggered Protocol for the Treatment of Alcohol Withdrawal Syndrome in Neurocritical Care Patients

(10-072) Assessing Tranexamic Acid Use in Intracranial Hemorrhages Irrespective of Severity

(10-073) Comparing Different Dosing Strategies of Prothrombin Complex Concentrate in Factor Xa Inhibitor-Related Bleeds

(10-074) Evaluating the Clinician Response to Coagulase-negative Staphylococcus Species Detected by the BCID2 Blood Culture Panel in a Retrospective Study

(10-075) Treatment Evaluation of Euglycemic Diabetic Ketoacidosis in the ICU.

(10-076) Impact of Initial Parenteral Anticoagulation on Direct Oral Anticoagulant Loading Dose for Acute Venous Thromboembolism: Multicenter Study

(10-077) Daptomycin plus ceftaroline continuation vs de-escalation to monotherapy in methicillin-resistant staphylococcus aureus bacteremia after blood culture clearance

(10-078) Comparison of Pain Management Efficacy and Cost of Local Infiltrative Agents Administered in Total Knee Arthroplasties and Total Hip Arthroplasties

(10-079) Comparison of Lokelma versus Kayexalate for Acute Hyperkalemia: A Single-Center Retrospective Analysis

(10-080) Evaluation of Patient Outcomes after Implementation of Formulary Change from Alteplase to Tenecteplase in Acute Ischemic Stroke

(10-081) Telehealth vs In-Person Pharmacist Led Ambulatory Care Visits for Diabetes Control

(10-082) Evaluating the Impact of Education on the Total Duration of Antimicrobial Therapy

(10-083) Impact of Initial Parenteral Anticoagulation on Direct Oral Anticoagulant Loading Dose for Acute Venous Thromboembolism: Multicenter Study

(10-084) Intravenous Metoprolol for Management of Atrial Fibrillation with Rapid Ventricular Response in the Emergency Department: A Medication Use Evaluation

(10-085) Outcomes of In-person versus Telehealth Encounters for Ambulatory Care Patients in Pharmacotherapy Clinics

(10-086) Length of Antibiotic Therapy in Hospitalized Patients with Contaminated Blood Cultures

(10-087) Evaluation of the Use of Alteplase/Dornase Alfa for Intrapleural Fibrinolytic Therapy in Parapneumonic Effusion and Empyema

(10-088) Surgical Site Infection Prophylaxis in Cesarean Section: Analysis of Antibiotic Variables and Impact on Outcomes

(10-089) Evaluation of a Scoring Criteria within a Clinical Decision Support Tool for Clinical Pharmacy Services

(10-090) Compliance with Range Orders in the Management of Pain

(10-091) Intravenous Pantoprazole Use Post-Implementation of Intermittent Dosing Strategy for Upper Gastrointestinal Bleed

(10-095) Evaluation of Enoxaparin Dosing for Venous Thromboembolism Prophylaxis in Obese Medical and Bariatric Surgery Patients at a Community Health System

(10-096) Evaluation of Intravenous Push Levetiracetam Time to Administration and Incidence of Adverse Events

(10-097) Utilization of the Behavioral Activity Rating Scale assessment and its Impact on Acute Agitation Management in the Emergency Department

(10-098) Streptococcal Rapid Antigen Diagnostic Test and Throat Culture Impact on Pharyngitis Treatment in Four Community Hospital Emergency Departments

(10-099) Evaluation of hypoglycemic events within 24-hours of insulin administration

(10-100) Evaluation of Digoxin Immune Fab Utilization for Digoxin Toxicity

(10-101) Impact of Pharmacist Involvement in Transition of Care of ICU patients

(10-102) Antibiotic Turnaround Time in Severe Sepsis/Septic Shock

(10-103) Clinical Impact of a Rapid Diagnostic Test and Pharmacist Intervention in Patients with Bloodstream Infections

(10-104) Effect of Discharge Medication Reconciliation Review by Pharmacists on Readmission Rates in Patients with Chronic Kidney Disease

(10-105) Evaluate Phenobarbital Usage For Alcohol Withdrawal After Order Set Implementation

(10-106) Impact of Implementing an Our Practice Advisory for Naloxone Co-Prescribing in at-Risk Patients

(10-107) Opioid Requirements Before and After the Implementation of Scheduled Acetaminophen in Cardiac Surgery Patients

(10-108) Title: Evaluation of Inpatient Cangrelor Utilization

(10-109) Retrospective Review of Ketorolac Dosing in a Community Hospital Emergency Department

(10-110) Enhancing OPA Effectiveness

(10-111) Trauma and Thrombosis: Transforming VTE Prophylaxis Practices

(10-112) Meropenem - the VIP (Very Important Pathogens) Only Drug: A Medication Use Evaluation

(10-113) To DRIP, or Not To DRIP: Evaluating DRIP Scores and Multidrug-Resistant Organism Risk Factors in Pneumonia Patients

(10-114) Evaluation of Heparin and the Incidence of Invasive Interventions in Patients with Acute Venous Thromboembolism and Acute Coronary Syndrome

(10-115) Illinois Health Professional Students’ Awareness and Perceptions of Community Pharmacist-Provided Clinical Services

(10-116) Determining the career paths of pharmacists who completed a PGY1 Community-Based Pharmacy Residency Program

(10-117) Determining the Perceptions and Awareness of Pharmacy as a Profession in Undergraduate Students

(10-118) Use of Inhaled Corticosteroid and Formoterol Combination Inhalers as Asthma Reliever Medication at a Safety Net Health System

(10-119) Effect of Multidisciplinary Antimicrobial Stewardship Team Intervention on Days of Therapy for Meropenem in an Adult Medical Intensive Care Unit

(10-120) Evaluating the Effects on Symptom Control of Adjunctive Phenobarbital in Moderate to Severe Alcohol Withdrawal Patients

(10-121) Impact of Reflex Serotonin Release Assay (SRA) on Heparin Induced thrombocytopenia (HIT)

(10-122) Evaluation of pain and sedation protocol in the Burn ICU

(10-123) Evaluation of Extended Courses of Phytonadione for Patients with Cirrhosis

(10-124) Evaluation of Intravenous Immunoglobulin Use at an Academic Medical Center

(10-125) Evaluation of oral antimicrobial appropriateness in patients receiving outpatient parenteral antimicrobials

(10-126) Evaluation of the Change in Intravenous Opioid Restriction Duration at an Academic Medical Center

(10-127) Meropenem Medication Use Evaluation Assessing Adherence to Febrile Neutropenia De-Escalation Guideline

(10-128) Assessing the Appropriateness of Cefepime Avoidance in the Neuro ICU

(10-129) Evaluation of Adherence to Local Clostridioides Difficile Treatment Guidelines

(10-130) Evaluation of non-formulary use of Eltrombopag at Loyola University Medical Center

(10-131) Evaluation of Discharge Medication Reconciliation Errors on a General Medicine Teaching Service at an Academic Medical Center

(10-132) Evaluation of Fidaxomicin Use Criteria Adherence

(10-133) Medication Use Evaluation of Long-Acting Injectables

(10-134) Descriptive Analysis of Pharmacist Impact on New Anticoagulant Therapy Prior to Community Hospital Discharge

(10-135) Impact of Pharmacist Intervention in Patients with Beta-Lactam Allergies at a Community Hospital

(10-136) Evaluation of Appropriate Intravenous Push Antihypertensive Medication Use for the Treatment of Inpatient Asymptomatic Hypertension at an Urban Safety-Net Hospital

(10-137) Appropriateness of Vancomycin: A Retrospective Evaluation

(10-138) Evaluation of Area Under the Concentration-Time Curve Guided Vancomycin Dosing using Bayesian Calculator on Vancomycin Monitoring

(10-139) Management of Diabetic Ketoacidosis, Hyperglycemic Hyperosmolar State and Mixed Diabetic Ketoacidosis/Hyperglycemic Hyperosmolar State

(10-140) Association between Antibiotic Spectrum and Efficacy of Lactobacillus casei, Lactobacillus acidophilus, and Lactobacillus rhamnosus in Preventing Clostridioides difficile Infection in Hospitalized Adult Patients

(10-141) Pharmacist Impact Time to Antibiotics in Sepsis

(10-142) Impact of Empiric Vancomycin and Piperacillin/Tazobactam vs. Ceftriaxone on Mortality in Community Acquired Sepsis

(10-143) Retrospective Review of Sodium-Glucose Cotransporter-2 inhibitors in Patients with Heart Failure on Discharge

(10-144) Impact of Trauma VTE Prophylaxis Order Panel on Adherence of Guideline Recommended VTE Prophylaxis in Trauma Patients

(10-145) Evaluation of the Safety and Efficacy of Subcutaneous Heparin Prophylaxis in Patients Undergoing Continuous Renal Replacement (CRRT)

(10-146) Changes in Tobacco Usage in Patients Taking GLP-1 Receptor Agonists or GIP/GLP-1 Receptor Agonists

(10-147) Reducing Community-Acquired Pneumonia Treatment Duration Rates

(10-148) Cost-Benefit Analysis of Using Premix versus Compounded Oxytocin, Dexmedetomidine, and Bupivacaine and Fentanyl Epidural Continuous IV Infusions

(10-149) Medication Use Evaluation of Rush University Medical Center’s Non-Formulary Medication Requests

(10-150) Impact of Pharmacist on Continuous Glucose Monitoring Usage and Management of Patients with Type 2 Diabetes in the Primary Care Setting

(10-151) Tikosyn Inpatient Initiation Pathway

(10-152) Evaluating Guideline Adherence for Venous Thromboembolism Prophylaxis in Trauma Patients

(10-153) Impact of Emergency Medicine Pharmacists on Door-to-Needle Times with Use of Tenecteplase for Acute Ischemic Stroke

(10-154) Evaluation of Time to Reach Therapeutic Anticoagulation with Heparin Infusions in a Single Community Hospital

(10-155) Impact of Pharmacist-led Medication Therapy Management (MTM) Visits on Medication Access, Adherence, and Clinical Outcomes for Patients Prescribed Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists

(10-156) Effect of Inpatient Medicated Assisted Recovery Consult Service on Re-Presentation Rates for Patients with Opioid Use Disorder

(10-157) Analysis of Heparin Dosing in Neonates Undergoing Therapeutic Hypothermia on Extracorporeal Life Support

(10-158) Incidence of Mycobacterium tuberculosis Screening and Detection in People Living With Human Immunodeficiency Virus Who Are In Custody Within the Illinois Department of Corrections

(10-159) Automated Reminder Messages to Patients with Past Pharmacogenomics Results in a Community Health System

(10-160) Evaluation of Euglycemic Diabetic Ketoacidosis in Patients Using Sodium-glucose cotransporter-2 inhibitors

(10-161) Evaluation of Left Ventricular Ejection Fraction Improvement and Guideline Directed Medical Therapy Prescribing Trends in Patients with Newly Reduced Ejection Fraction

(10-162) Utilizing Long-Acting Inhalers Patients Hospitalized with an Acute COPD Exacerbation

(10-163) Efficacy of Midodrine Use Post-Kidney Transplantation for Tapering off Vasopressors

(10-164) Hemodynamic Effects of Push-Dose Epinephrine Administration: A Retrospective Cohort Study

(10-165) Assessing Food Provision in Correctional Facilities Utilizing Glecaprevir/Pibrentasvir for Hepatitis C Treatment

(10-166) HCAP: Are We Still Using This 5 Years Later?

(10-167) Screening and Incidence of Sexually Transmitted Infections (STIs) among Persons with HIV (PWH) in the Illinois Department of Corrections (IDOC)

(10-168) Antithymocyte globulin Induction Dosed on Ideal Body Weight: Absolute Lymphocyte Cell (ALC) Depletion in Kidney Transplant Recipients with and without Obesity

(10-169) The Adaptive Role of Transplant Pharmacists – A Comparative Analysis of Glycemic Management and its Outcomes on Kidney Transplant Recipients

(10-170) Assessing Pharmacist Impact on Post-Intubation Analgesia and Sedation in the Emergency Department

(10-171) Comparison of Angiotensin II (Giapreza) Use for Perioperative Hypotension surrounding Kidney Transplantation between Black and non-Black Patients

(10-172) Measuring the Impact of a Resident Clinical Pharmacist On-call Program on Resident Physician Training

(10-173) Efficacy and Safety Comparison of Letermovir Versus Valganciclovir for Use in Cytomegalovirus Prophylaxis in Adult Kidney Transplant Recipients

(10-174) Effects of a Surgical Opioid Avoidance Protocol (SOAP) in Pancreas Transplant Recipients

(10-175) Evaluation of Antibiotic Therapy Among Patients with Contaminated Blood Cultures Identified by Rapid Diagnostic Testing

(10-176) Optimization of Outpatient Infusion Services: Trends and Insights

(10-177) Impact of a Pharmacist Driven Blood Culture Algorithm in the Emergency Department

(10-178) Impact of Ambulatory Care Pharmacist Interventions on Patients Initiated on a Glucagon-Like Peptide-1 Receptor Agonist (GLP-1 RA) in a Weight Management Clinic

(10-179) Utilization of Illinois Drug Reuse Opportunity Program (I-DROP) Medications at a Single Community Hospital

(10-180) Evaluation of Agitation and Withdrawal Management in a Community Hospital Mixed ICU

(10-181) Impact of Pharmacist Led Antibiotic Stewardship on Infection Control in Community Hospitals: A Retrospective Analysis of MRSA Rates

(10-182) Evaluating the impact of pharmacist intervention and protocol adherence for initiation of sotalol and dofetilide for atrial fibrillation in an inpatient setting.

(10-183) Evaluation of Dobutamine versus Milrinone Use for Cardiogenic Shock in a Cardiac Intensive Care Unit Setting

(10-184) Effect of Vitamin K Supplementation on Elevated INR in Hospitalized Patients with Cirrhosis

(10-185) Evaluation of a Pharmacist-Driven Discontinuation of Antibiotics After Discharge from the Emergency Department with Negative Urine Cultures

(10-186) Evaluating Efficacy of a Pharmacist-Driven 48-Hour Broad-Spectrum Antibiotic De-escalation Process 1-Year Post-Implementation

(10-187) Impact of Pharmacist Management of Continuous Glucose Monitors on Diabetes Outcomes

(10-188) Piloting Chronic Care Management Billing Involving Pharmacist in Primary Care

(10-189) Impact of Direct Oral Anticoagulant (DOAC) Management Following Implementation of Pharmacist-Directed Monitoring Service

(10-190) Evaluating the Effectiveness of N-acetylcysteine in Acute Alcoholic Hepatitis

(10-191) Evaluating Administration of Norepinephrine: An Analysis of Duration of Peripheral Administration

(10-192) Evaluation of Patient Risk Factors for Diagnosis and Treatment of Gonorrhea and Chlamydia in a Community Emergency Department

(10-193) Evaluating the Impact of Psychiatric Pharmacists on Patient Outcomes and Healthcare Costs: A Retrospective Analysis

(10-194) Evaluation of Adherence to Evidence-Based Recommendations for Patients with Hypertensive Disorders of Pregnancy

(10-195) EPT in the ED

(10-196) Hyperkalemia Treatment Improvement to Decrease Incidence of Hypoglycemia

(10-197) Outcomes of Electronic Medical Record-Based Antimicrobial Stewardship on Treatment Duration: A Retrospective Examination

(10-198) Comparative Analysis of Glycemic Control Using Different Continuous Glucose Monitoring (CGM) Devices

(10-199) Insulin Dose Change in Patients Starting and Titrating Injectable GLP-1 Receptor Agonists Under Pharmacist Management

(10-200) Association Between Vancomycin Area Under the Curve and Nephrotoxicity: A Retrospective Study

(10-201) Naloxone (Narcan®) Medication Use Evaluation at Indiana University Health

(10-202) Assessing Time to Appropriate Antibiotic Therapy with the Use of Blood Culture Rapid Diagnostic Systems in Combination with Pharmacist-Led Stewardship Efforts

(10-204) Real-world Incidence of Depression and Impact on Adherence in Patients Taking Oral Oncolytics

(10-205) Evaluation of Insulin After Initiation of Once-Weekly Glucagon-Like Peptide-1 (GLP-1) or GLP-1/Glucose-Dependent Insulinotropic Polypeptide (GIP) Receptor Agonists in Patients with Type-2 Diabetes Mellitus

(10-206) Implementation of a Pharmacist in the Management of Postpartum Hypertension in an Obstetrics and Gynecology Clinic

(10-207) Evaluation of the Effectiveness of Pharmacist Follow-Up in Primary Care Clinics for Urgent Care Patients with Hypertension

(10-208) Evaluation of a pharmacist-driven urgent care microbiology result review program

(10-209) Discharge Discrepancies: Impact on High-Risk Medications, High-Risk Populations, and Readmission Rates

(10-210) Assessment of Education Regarding the Evaluation of Beta Blocker Initiation/Continuation Timing in Heart Failure Diagnosis and Exacerbation

(10-211) Comparative Efficacy of 3-factor versus 4-factor Prothrombin Concentrate for Reversal of Direct Oral Anticoagulant Related Intracranial Hemorrhage

(10-212) Evaluating the Impact of Multidisciplinary Care on Opioid Use Disorder: A Retrospective Study of Buprenorphine/Naloxone-Assisted Treatment in a Family Medicine Residency

(10-213) Effect of Pharmacist-Led Education on Optimized Antibiotic Use in Uncomplicated Gram-Negative Bloodstream Infections

(10-214) Impact of 72 hour hang time on central line associated bloodstream infections in neonatal intensive care unit

(10-215) Fosfomycin for Catheter-Associated Urinary Tract Infection Prevention in the Intensive Care Unit

(10-216) Impact of Electronic Medical Record Changes on Preoperative Antibiotic Prophylaxis and Surgical Site Infections

(10-217) Evaluating The Appropriateness of Stress Ulcer Prophylaxis Ordering in Non-Critically Ill Hospitalized Patients

(10-218) Anticoagulation Strategies after Left Ventricular Thrombus

(10-219) Dofetilide Initiation in a Tertiary Medical Center: A Medication Use Evaluation

(10-220) Discharge Antibiotic Use in Patients Hospitalized with Chronic Obstructive Pulmonary Disease (COPD) Exacerbations

(10-221) Optimization of Beta-Lactam Dosing in Critically Ill Patients with Continuous Veno-Venous Hemofiltration or Augmented Renal Clearance

(10-222) Drop-it Like it’s Hot: A Droperidol Medication Use and Efficacy Evaluation in a Community Teaching Hospital

(10-223) Evaluation and Optimization of Outpatient Parenteral Antimicrobial Therapy Laboratory Monitoring for Beta-Lactam Antibiotics

(10-224) Medication Use Evaluation of Fecal Microbiota Spores, Live-brpk for the Prevention of Recurrent Clostridioides difficile Infection

(10-225) Stepping Back: Evaluating Antipseudomonal Antibiotic Use in Diabetic Foot Infections

(10-226) Optimizing Serum Magnesium Monitoring and Replacement in a Community Hospital

(10-227) Comparing Cardiometabolic Monitoring and Side Effect Management in a Pharmacist-led Ambulatory Clozapine Clinic versus Standard Care

(10-228) Evaluation of Cardiometabolic Monitoring in Patients Taking Antipsychotic Agents within a ​Community Mental Health Center​

(10-229) Evaluation of Medications Utilized and Proper Management of Hyperuricemia in Patients with Tumor Lysis Syndrome (TLS)

(10-230) Penicillin Allergy De-Labeling

(10-231) Evaluation of a Pharmacy-Driven Empiric Insulin Glargine Dose Reduction Protocol

(10-232) Pharmacist Impact on Glycemic Control when Transitioning from Intravenous Infusion to Subcutaneous Insulin

(10-233) Analysis of readmission rates for patients with diabetes managed in the outpatient setting by pharmacists versus physicians: a retrospective study

(10-234) Efficacy of Diltiazem Bolus Dosing Strategies in Atrial Fibrillation with Rapid Ventricular Response

(10-235) Evaluating Guideline-Directed Medical Therapy Compliance and Its Effect on Readmission Rates in Patients with Heart Failure with Reduced Ejection Fraction

(10-236) Prescribers Adherence to Guideline-directed Medical Therapy in Patients with Albuminuric Chronic Kidney Disease and Type 2 Diabetes: a nephro-protective view

(10-237) Venous Thromboembolism (VTE) prophylaxis in Post knee and hip replacement: link the practice to the evidence at Sheikh Khalifa Medical City

(10-238) Evaluation of Antifungal Use in Adult Patients at a Tertiary Care Academic Hospital: A Retrospective Study

(10-239) Impact of a Pharmacist-Led Initiative on the Identification and Management of Antifungal Drug-Drug Interactions in Adult Patients at a Lebanese Medical Center: A Retrospective Study

(10-240) Assessment of Patients' adherence to Levofloxacin Extemporaneously Prepared in Pediatric Oncology Hospital

(10-242) Impact of Pharmacokinetic Monitoring of Biological Therapies on Inflammatory Bowel Disease in Pediatric Patients

(10-243) Paclitaxel Pharmacokinetics and Neuropathy in Breast Cancer Patients: Insights from a Retrospective Study

(10-244) Use of Omalizumab for the Treatment of Refractory Bullous Pemphigoid with Concomitant Risankizumab Therapy for Psoriasis

(10-245) Review and Analysis of Drug-drug Interactions in Patients Starting Oral Onco-Hematologic Treatments

(10-246) Assessment of Refeeding syndrome and adequacy of nutritional support in hospitalized patients receiving parenteral nutrition

(10-247) Ensuring patient safety through reducing medication prescribing errors

(10-248) Accuracy of ChatGPT in Medication Therapy Management

(10-249) Impact of Medication Shortages on Cancer Patients in Lebanon

(10-250) Analysis of Clindamycin and Vancomycin Use and Reported Beta-Lactam Allergy in Procedural Antimicrobial Prophylaxis: Post Practice Change Analysis

(10-251) Retrospective Chart Review of Perioperative Glycemic Management Protocol in Colorectal and Gynecologic Oncology Surgery Patients

(10-252) Creating a Guideline for Safe Medication Handling in Education, Simulation, and Equipment Management in a Community Hospital

(10-253) Assessment of Pharmacist-Led Erythropoiesis-Stimulating Agent Dosing in Patients with Anemia of Chronic Kidney Disease

(10-254) Evaluation of Post-Operative Urinary Tract Infections (UTIs) in Bariatric Surgery Patients at a Community Hospital

(10-255) Assessment of Pharmacological Interventions in Trauma Patients in Response to Thromboelastography (TEG) Results

(10-256) Assessment of Inpatient Antibiotic Use for Aspiration Pneumonia

(10-257) Evaluation of First-Dose Loop-Diuretic Utilization for Acute Heart Failure Exacerbation in the Emergency Department

(10-258) Evaluating the Appropriate Utilization of Vancomycin According to CDC Recommendations in Hospitalized Patients at MercyOne North Iowa

(10-259) The Impact of Pharmacist-Reviewed Discharge Medication Reconciliation at Hospital Discharge on Patient Outcomes

(10-260) Implementation of a Streamlined Process for Early Discharge with Dalbavancin for Patients with Acute Bacterial Skin and Skin Structure Infections

(10-261) Pharmacist's Role in Enhancing Clostridioides difficile Diagnostic Stewardship

(10-262) Evaluating De-prescribing Opportunities for Gastrointestinal Prophylaxis and Acute Delirium Agents in Post-Intensive Care Unit (ICU) Patients

(10-263) Evaluating Intravenous Hydralazine for Blood Pressure Management in Acute Care Patients

(10-264) Pharmacists’ Role in Adherence to Clinical Practice Guidelines for the Management of Clostridioides Difficile Infections in a Community Hospital

(10-265) Evaluation of Intravenous Albumin Usage and Cost Avoidance in Adult Inpatients

(10-266) Improving Appropriate Treatment: A Guide to Oral Step-Down Therapy for Gram Negative Bacteremia

(10-267) Integration of Palliative Pharmacists to Standard Oncologic Care of Patients with Head and Neck Cancer

(10-268) The Impact of a Meds-to-Beds Auto-Enrollment Initiative on Readmission Rates

(10-269) Impact of Standardized Fluid Resuscitation and Laboratory Procedure Prior to Initiation of Continuous Intravenous Insulin for the Treatment of Diabetic Ketoacidosis

(10-270) Impact of a Patient Assistance Card Program on 30-Day Hospital Readmission Rate

(10-272) Efficacy of a 1 gram Maximum Daily Dose vs a 2 gram Maximum Daily Dose of Ceftriaxone in Pediatric Infections

(10-273) Impact of Albumin Dose Standardization in Large Volume Paracentesis

(10-274) An Evaluation of Inpatient Medication History Efficacy Among Different Healthcare Professions and Modalities

(10-275) Did the conversion to Tenecteplase from Alteplase for thrombolysis treatment in acute ischemic stroke patients affect patient outcomes and financial metrics?

(10-276) Evaluation of Surgical Site Infections in a Community Hospital Setting

(10-277) A Retrospective Study Validating and Assessing Safety of an Updated NICU Vancomycin Dosing Protocol

(10-278) Empowering Pharmacists to Enhance Patient Experience and Improve Medication Safety in Chronic Kidney Disease Patients

(10-279) Maximizing Opioid Stewardship through Intravenous Opioid Optimization in a Community Hospital

(10-280) Analyzing alert firing to lessen alert fatigue in a community hospital.

(10-281) Implementation of Dose-Rounding Policy in Patients Receiving Trastuzumab, Rituximab, or Bevacizumab and their Respective Biosimilars in an Outpatient Oncology Clinic

(10-282) Incidence of ketoacidosis with sodium-glucose co-transporter-2 inhibitors in patients with Type 2 Diabetes, and or Heart Failure.

(10-283) Intravenous Diltiazem Used for Atrial Fibrillation and Association with Heart Failure Outcomes

(10-284) Cost-Benefit Analysis of Dornase Alfa in the Treatment of Chronic Obstructive Pulmonary Disease

(10-285) Awareness During Paralysis after Rapid Sequence Intubation in the Emergency Department

(10-286) Evaluating the Effectiveness of Weight-Based Adenosine Dosing in Conversion of Supraventricular Tachycardia in the Emergency Department

(10-287) Prophylactic Amiodarone vs. Early Discontinuation After Coronary Artery Bypass Grafting and/or Valve Surgery via Sternotomy for Prevention of Postoperative Atrial Fibrillation

(10-288) An Evaluation of Remdesivir Utilization at a Large Academic Medical Center

(10-289) Evaluation of Patient’s Own Medication Use within an Academic Medical Center

(10-290) Comparison of Clinical Outcomes with Ceftriaxone for Enterobacterales Bacteremia in Obese versus Non-obese Patients

(10-291) Evaluation of the Efficacy and Safety of Short Versus Long Antimicrobial Therapy for the Treatment of Gram-negative Bacteremia in Patients with Hematologic Malignancies

(10-292) Appropriateness of rabies vaccines and human rabies immune globulin (HRIG) use for post-exposure prophylaxis: A medication use evaluation

(10-293) Evaluation of Perioperative Blood Glucose Management in Patients Undergoing Orthopedic and Spine Surgeries

(10-294) Recurrent Venous Thromboembolism in Patients With Abbreviated Versus Full Lead-in Dosing of Apixaban or Rivaroxaban​

(10-295) Rate of stent thrombosis and/or treatment failure in low dose versus high dose eptifibatide bridge post-intracranial stent placement at The University of Kansas Health System

(10-296) Incidence of Urinary Tract Infections in Patients Taking Sodium-Glucose Cotransporter 2 Inhibitors and Subsequent Rate of Discontinuation

(10-297) Retrospective Evaluation of Oral Antibiotic Dosages Based on Renal Function in Elderly Patients Discharged from a Community Hospital Emergency Department

(10-298) Incidence of Prescription Medication Discrepancies in a Community Hospital with and without a Designated Medication Reconciliation Pharmacy Technician

(10-299) Comparison of Intravenous Terbutaline and Continuous Inhaled Albuterol for Status Asthmaticus in Pediatric Intensive Care Unit Patients

(10-300) To Impel Anticoagulation with Impella or Not

(10-301) Incidence of Hyponatremia Overcorrection with Hypertonic Saline Use

(10-302) Risk Factors of Acute Kidney Injury in Patients with Traumatic Brain Injuries Receiving Hypertonic Saline

(10-303) Door-to-Prothrombin Complex Concentrate Administration in Traumatic and Atraumatic Factor-Xa Inhibitor Associated Intracerebral Hemmorhage

(10-304) Evaluation of Haloperidol vs Droperidol for Undifferentiated Abdominal Pain in The Emergency Department (DREAMER II)

(10-305) Incidence of Methicillin-Resistant Staphylococcus aureus (MRSA) in Sepsis of Unknown Source

(10-306) Risk Factors for Calaspargase Pegol-mknl Hypersensitivity Reactions in Pediatric Acute Lymphoblastic Leukemia

(10-307) Analysis of Clinical Outcomes in Patients Treated with Inclisiran

(10-308) Evaluating Diuretic Optimization in Hospitalized Patients with Heart Failure Using Remote Dielectric Sensing (ReDS) Vest Analytics

(10-309) Comparing Pharmacist Led Weight Management Clinic to Primary Care Managed Outcomes of Wegovy

(10-310) Assessing the Influence of an Electronic Health Record Decision Support Panel on Inpatient Antibiotic Therapy Duration for Sepsis

(10-311) Guideline Adherence and Outcomes Among Staphylococcus aureus Bacteremia Patients before and after Routine Review by Infectious Diseases Pharmacist and Tele-Antimicrobial Stewardship Physician.

(10-312) Extended-Interval Dosing vs Standard Dosing of Immune Checkpoint Inhibitors at a Community Outpatient Oncology Infusion Center

(10-313) Comparison in Clinical Outcomes with Lorazepam vs. Midazolam use in Patients Admitted to a Community Hospital for Alcohol Withdrawal

(10-314) Impact of Comprehensive Education on Antibiotic Duration of Therapy for Community Acquired Pneumonia in a Community Hospital

(10-315) Evaluation of an Automated Dispensing Cabinet Patient Medication Management Software’s Impact on Medication Dispense Rates from a Central Distribution Pharmacy in a Community Hospital

(10-316) • Observation of Error Rates on Extended-Infusion Antibiotics at a Community Hospital Observation of Error Rates on Extended-Infusion Antibiotics at a Community Hospital

(10-317) Outcomes of a Transitions of Care Pharmacy Program Expansion

(10-318) Impact of Implementing an Order Panel for Insulin and Dextrose Dosing for the Management of Hyperkalemia in Emergency Department Patients